Elanco’s Credelio receives FDA Emergency Use Authorization

The U.S. FDA issued an Emergency Use Authorization for Credelio chewable tablets, concluding that, based on the scientific evidence available, it is reasonable to believe that Credelio may be effective in treating New World screwworm infestations in dogs and puppies and the known and potential benefits of the product outweigh its known and potential risks. Credelio is sponsored by Elanco (ELAN) US Inc. based in Indianapolis, Indiana.